Theravant Corporation develops, produces, markets and sells high quality, affordable products for the medical aesthetic marketplace. Driven by a highly skilled product development team with a long history of innovation in the medical-aesthetic marketplace, the company plans to develop a steady stream of new products for both the physician office and the spa market. The TheraClear™ Acne System, a revolutionary product for the treatment of acne is the company’s first product. It is now being used to treat acne patients in more than 20 countries. Acne is the most common skin disorder that affects both men and women of all races and often has deep emotional and psychological effects. Approximately 80 percent of all people between the ages of 11 and 30 suffer from acne with many continuing to have this condition into their 40s and beyond. This breakthrough acne treatment combines a gentle vacuum with a painless therapeutic broadband light. The system is FDA-cleared to treat the widest range of acne in all skin types: mild to moderate inflammatory acne (Acne Vulgaris), Comedonal Acne and Pustular Acne. As the premiere non-pharmaceutical acne system on the market, TheraClear™ treatment is not only painless but also highly efficacious. It works by gently cleansing the pores through the extraction of sebum, dead skin cells, and bacteria using TheraClear™’’s gentle deep extraction Technology. The blocked pathways are cleared so oral and topical medications work better. The TheraClear™ therapy results in markedly clearer skin and dramatic improvement in skin texture with a reduction in pore size. Additionally, most patients see consistent and immediate results within 24-48 hours post treatment.